Clinical trial
New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific…
NCT00035854 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00035854 |
|---|---|
| Title | New Antibiotic to Treat Pediatric Patients With Infections Due to a Specific Bacteria (Vancomycin-Resistant Enterococcus) |
| Official title | Linezolid IV/PO for the Treatment of Vancomycin-Resistant Enterococcus Infections in Children |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bacterial Infections |
| Intervention type | Drug |
| Interventions | Zyvox® / Linezolid |
| Enrollment | 13 |
| Start date | Feb 1, 2002 |
| Completion | May 1, 2004 |
| First posted | May 7, 2002 |
| Last update posted | Aug 14, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: